Despite Dip In Pharma M&A, Oncology Remains Hot
Although overall deal value in the pharmaceutical industry fell last year, oncology and diagnostics remain hot, and any big mergers on the horizon will likely center on this area, according to...To view the full article, register now.
Already a subscriber? Click here to view full article